Serum antibodies to distinct epitopes of the tissue‐type plasminogen activator (t‐PA) in patients with systemic lupus erythematosus

Publisher Website
Google Scholar
Abstract
Defective fibrinolysis due to decreased tissue‐type plasminogen activator (t‐PA) activity is a well‐established finding in patients with systemic lupus erythematosus (SLE). The possibility that this decrease in t‐PA activity may be related to the presence of autoantibodies directed against t‐PA, and the possible role of these autoantibodies in the patho‐physiology of fibrinolysis in SLE, were investigated. Serum samples from 115 SLE patients and 63 normal volunteers were analyzed for the presence of such antibodies. The search for antibodies to t‐PA was performed by means of several systems, allowing for the identification of epitopes presented in different conformational physical states of t‐PA: free or associated to its inhibitor (PAI‐1) in plasma, specifically bound to fibrin surface, or passively adsorbed to solid supports. Antibodies in variable amounts were detected by all systems used; however, t‐PA activity was not inhibited by the IgG fraction of the positive sera in a fibrin‐agar fibrinolysis system. Moreover, the demonstration of serum anti‐t‐PA antibodies was not associated with clinical or laboratory abnormalities related to vasoocclusive episodes. These results indicate that, as in the case of other autoantibodies, their detection in serum does not imply their direct participation in the pathophysiology of thrombosis in SLE.

This publication has 14 references indexed in Scilit: